Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese Participants”

229 trials

Showing 20 of 229 results

Early research (Phase 1)Looking for participantsNCT07723118
What this trial is testing

Assess the Pharmacokinetics, Safety and Tolerability of Single-dose Adagrasib (BMS-986503) in Healthy Participants of Japanese Descent

Who this might be right for
Healthy Participants
Mirati Therapeutics Inc. 10
Early research (Phase 1)Study completedNCT02835508
What this trial is testing

Pharmacokinetic Study of JNJ-56021927 When Taken Orally as Tablet Formulation in Healthy Male Japanese Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 18
Early research (Phase 1)Ended earlyNCT04586920
What this trial is testing

LY3509754 in Healthy Non-Japanese and Japanese Participants

Who this might be right for
Healthy
Eli Lilly and Company 104
Early research (Phase 1)Study completedNCT05229562
What this trial is testing

See How BIIB122 Works in the Human Body, and to Evaluate it's Safety, and Tolerability in Healthy Adult Japanese, Chinese, and Caucasian Participants

Who this might be right for
Healthy Volunteer
Biogen 84
Early research (Phase 1)Study completedNCT05174013
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK3858279 in Healthy Caucasian, Chinese and Japanese Participants

Who this might be right for
Pain
GlaxoSmithKline 33
Early research (Phase 1)Study completedNCT07335198
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European Ancestry

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 30
Early research (Phase 1)Study completedNCT05845645
What this trial is testing

Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to Test Safety, Tolerability, and Pharmacokinetic (PK) of UCB0599 in Healthy Japanese and Chinese Participants in Part B

Who this might be right for
Healthy Study Participants
UCB Biopharma SRL 73
Early research (Phase 1)Study completedNCT06970301
What this trial is testing

Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, and Chinese Participants

Who this might be right for
Healthy Study Participants
UCB Biopharma SRL 32
Early research (Phase 1)Study completedNCT03859219
What this trial is testing

Evaluate Safety and Tolerability of Single Ascending Doses of Rozanolixizumab Administered by Subcutaneous Infusion in Healthy Japanese, Chinese and Caucasian Study Participants

Who this might be right for
Healthy-volunteers
UCB Biopharma S.P.R.L. 65
Early research (Phase 1)Study completedNCT01995526
What this trial is testing

Insulin Peglispro in Healthy Male Japanese Participants

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 11
Early research (Phase 1)Ended earlyNCT03618160
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of Subcutaneous (SC) Injections of JNJ-64565111 in Healthy Male Japanese Participants and to Assess Pharmacokinetics Following Subcutaneous Injections of JNJ-64565111 in Healthy Male Caucasian Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 42
Early research (Phase 1)Study completedNCT05110976
What this trial is testing

Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists

Who this might be right for
Asthma
AstraZeneca 170
Early research (Phase 1)Study completedNCT05062200
What this trial is testing

JNJ-77242113 in Healthy Japanese and Chinese Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 36
Early research (Phase 1)Study completedNCT04002752
What this trial is testing

JNJ-73763989 in Healthy Japanese Adult Participants

Who this might be right for
Healthy
Janssen Sciences Ireland UC 25
Early research (Phase 1)Study completedNCT06715670
What this trial is testing

Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese Participants

Who this might be right for
Liver Cirrhosis
AstraZeneca 30
Early research (Phase 1)Study completedNCT04302064
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending and Multiple Doses of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Healthy Japanese Participants

Who this might be right for
Healthy Participants
Ionis Pharmaceuticals, Inc. 24
Early research (Phase 1)Study completedNCT05932641
What this trial is testing

Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants

Who this might be right for
COVID-19, SARS-CoV-2
AstraZeneca 24
Early research (Phase 1)Study completedNCT05995691
What this trial is testing

Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese Participants

Who this might be right for
Healthy Volunteers
Amgen 179
Early research (Phase 1)Ended earlyNCT06009237
What this trial is testing

Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese Participants

Who this might be right for
Healthy Volunteers
AbbVie 24
Early research (Phase 1)Study completedNCT06069895
What this trial is testing

Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants

Who this might be right for
Healthy Participants
Novo Nordisk A/S 170
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation